This invention relates to the field of
biotechnology, specifically to the construction and application of a Benzodiacetic tobacco
chassis for synthesizing
isoflavones. This invention reconstructs the upstream pathway for isoflavone synthesis in Benzodiacetic tobacco, further identifies and screens key rate-limiting enzymes for isoflavone synthesis in Benzodiacetic tobacco, and utilizes 2A peptides to co-express multiple
key genes, further introducing
flavonoid synthesis transcription factors to construct a Benzodiacetic tobacco
chassis for synthesizing
isoflavones. This Benzodiacetic tobacco
chassis can efficiently synthesize
daidzein and
genistein. Furthermore, based on the constructed high-yield Benzodiacetic tobacco platform for
daidzein and
genistein, various
isoflavones can be further synthesized, such as
daidzein,
genistein,
puerarin, gentiopicrin, chickpea extract A, and stigmosiderin, paving the way for the industrialization of
plant biosynthesis of various bioactive isoflavones and thus possessing broad application prospects.